Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HOLOGIC Diagnostics

HOLOGIC Diagnostics offers innovative technology for cytology, molecular and perinatal testing that helps deliver ans... read more Featured Products: More products

Download Mobile App




Hologic Enters into Agreement with CDC for H5N1 Bird Flu Test Development

By LabMedica International staff writers
Posted on 19 Dec 2024

H5N1 avian influenza, commonly referred to as bird flu, is still spreading among wild birds globally and has led to outbreaks in poultry and dairy cows in the U. More...

S. Recently, several human cases of the virus have been reported among individuals who work with these animals. While the virus has caused mild illness in the U.S., severe cases have been reported in other countries. To prepare for a possible escalation of the current outbreak, Hologic (Marlborough, MA, USA) has entered into an agreement with the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) to develop reagents for H5N1 testing.

Hologic will collaborate with the CDC to create analyte-specific reagents (ASRs), which are the essential components in laboratory-developed tests that help identify specific diseases. These reagents will be aimed at detecting H5N1 bird flu. The contract will fund the proof-of-concept phase for the development of these ASRs, including primers and probes, which could be integrated into laboratory-developed tests (LDTs) for detecting the virus. Although Hologic does not plan to commercially release these ASRs at present, the company may consider this option if rapid H5N1 testing becomes necessary. The reagents are being developed for use with the Panther Fusion system, an advanced, fully automated molecular testing platform that facilitates fast and efficient testing for various infectious diseases, including SARS-CoV-2 (COVID-19).

The Panther Fusion system, which is widely used in public health laboratories, hospitals, and private labs across the U.S., has more than 1,700 units installed. Nearly 500 of these units are Panther Fusion systems capable of processing over 1,000 results daily, and they can rapidly increase testing capacity without needing additional equipment or operator training, which is particularly useful during outbreaks or pandemics. The system’s Open Access feature also allows labs to design and automate their own LDTs, seamlessly integrating them with FDA-approved in vitro diagnostic (IVD) assays, thereby reducing time and labor when compared to traditional manual testing.

The development of ASRs for H5N1 detection builds on Hologic’s established portfolio of diagnostic tools, including those used for COVID-19. In 2020, the company swiftly developed the Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay, which played a pivotal role in the global pandemic response, with over 68 million tests shipped to 40 countries that year. Hologic continues to innovate, including receiving FDA clearance in 2023 for a test capable of detecting SARS-CoV-2, influenza A and B, and RSV in a single patient sample.

“During the COVID-19 pandemic, our teams pivoted rapidly and rose to the challenge of developing critical tests to help curtail the virus’s spread,” said Jennifer Schneiders, Ph.D., President, Diagnostic Solutions. “Hologic’s proven expertise in assay development, innovative instrumentation and extensive reach uniquely position us well to proactively address ever evolving and emerging public health threats.”

Related Links:
Hologic 
CDC 


New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.